carbapenems has been researched along with 2-(3-methanesulfonylamino-1-propenyl)pyrrolidin-4-ylthiol-6-(1-hydroxyethyl)-1-methyl-1-carbapen-2-em-3-carboxylic acid in 14 studies
| Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) | Studies (2-(3-methanesulfonylamino-1-propenyl)pyrrolidin-4-ylthiol-6-(1-hydroxyethyl)-1-methyl-1-carbapen-2-em-3-carboxylic acid) | Trials (2-(3-methanesulfonylamino-1-propenyl)pyrrolidin-4-ylthiol-6-(1-hydroxyethyl)-1-methyl-1-carbapen-2-em-3-carboxylic acid) | Recent Studies (post-2010) (2-(3-methanesulfonylamino-1-propenyl)pyrrolidin-4-ylthiol-6-(1-hydroxyethyl)-1-methyl-1-carbapen-2-em-3-carboxylic acid) |
|---|---|---|---|---|---|
| 7,355 | 147 | 5,277 | 14 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 12 (85.71) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, SH; Kim, WB; Lee, MG | 6 |
| Kim, SH; Kim, WB; Lee, ED; Lee, MG; Lee, SD; Yang, J | 1 |
| Kim, SH; Kwon, JW; Lee, MG; Yang, J | 1 |
| Kim, SH; Kim, WB; Lee, MG; Shim, HJ | 1 |
| Kim, SH; Kwon, JW; Lee, MG | 1 |
| Kim, SH; Kim, WB; Kwon, JW; Lee, MG | 2 |
| Choi, SH; Kim, GW; Park, HS; Park, SW; We, JS | 1 |
| Kim, SH; Kim, WB; Kwon, JW; Lee, I; Lee, MG | 1 |
14 other study(ies) available for carbapenems and 2-(3-methanesulfonylamino-1-propenyl)pyrrolidin-4-ylthiol-6-(1-hydroxyethyl)-1-methyl-1-carbapen-2-em-3-carboxylic acid
| Article | Year |
|---|---|
Stability, tissue metabolism, tissue distribution, and blood partition of DA-1131, a new carbapenem.
Topics: Animals; Carbapenems; Drug Stability; Humans; Hydrogen-Ion Concentration; Rabbits; Rats; Time Factors; Tissue Distribution | 1995 |
Determination of a new carbapenem antibiotic, DA-1131, in rat plasma, urine, and bile by column-switching high-performance liquid chromatography.
Topics: Animals; Bile; Carbapenems; Chromatography, High Pressure Liquid; Half-Life; Hydrogen-Ion Concentration; Rats; Spectrophotometry, Ultraviolet | 1996 |
Determination of a new carbapenem derivative, DA-1131, in plasma and urine by high-performance liquid chromatography.
Topics: Animals; Carbapenems; Chromatography, High Pressure Liquid; Humans; Injections, Intravenous; Osmolar Concentration; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Spectrophotometry, Ultraviolet; Tissue Distribution | 1997 |
Pharmacokinetics of a new carbapenem, DA-1131, after intravenous administration to rats with uranyl nitrate-induced acute renal failure.
Topics: Acute Kidney Injury; Animals; Carbapenems; Injections, Intravenous; Male; Rats; Rats, Sprague-Dawley; Tissue Distribution; Uranyl Nitrate | 1998 |
Pharmacokinetics and tissue distribution of a new carbapenem DA-1131, after intravenous administration to mice, rats, rabbits and dogs.
Topics: Animals; Bile; Biliary Tract; Carbapenems; Dogs; Injections, Intravenous; Male; Mice; Mice, Inbred ICR; Rabbits; Rats; Rats, Sprague-Dawley; Tissue Distribution | 1998 |
Interspecies pharmacokinetic scaling of a new carbapenem, DA-1131, in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics.
Topics: Animals; Carbapenems; Dogs; Humans; Kidney; Male; Mice; Mice, Inbred ICR; Predictive Value of Tests; Rabbits; Rats; Rats, Sprague-Dawley; Species Specificity; Tissue Distribution | 1998 |
Pharmacokinetics of a new carbapenem, DA-1131, after intravenous administration to rats with alloxan-induced diabetes mellitus.
Topics: Alloxan; Animals; Carbapenems; Diabetes Mellitus, Experimental; Injections, Intravenous; Metabolic Clearance Rate; Rats; Rats, Sprague-Dawley; Tissue Distribution | 1998 |
No effect of probenecid on the renal excretion mechanism of a new carbapenem, DA-1131, in dogs.
Topics: Absorption; Animals; Carbapenems; Dogs; Kidney Tubules; Male; Probenecid; Renal Agents | 1998 |
Effect of probenecid on the renal excretion mechanism of a new carbapenem, DA-1131, in rats and rabbits.
Topics: Animals; Area Under Curve; Carbapenems; Chromatography, High Pressure Liquid; Creatinine; Drug Interactions; Injections, Intravenous; Male; Probenecid; Rabbits; Rats; Rats, Sprague-Dawley | 1999 |
Nephroprotective effect of betamipron on a new carbapenem, DA-1131, in rabbits.
Topics: Alanine; Animals; Carbapenems; Drug Interactions; Kidney Function Tests; Kidney Tubular Necrosis, Acute; Male; Protective Agents; Rabbits | 1999 |
Pharmacokinetic changes of a new carbapenem, DA-1131, after intravenous administration to spontaneously hypertensive rats and deoxycorticosterone acetate-salt-induced hypertensive rats.
Topics: Animals; Area Under Curve; Carbapenems; Desoxycorticosterone; Dipeptidases; Half-Life; Hypertension; In Vitro Techniques; Injections, Intravenous; Kidney; Liver; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Tissue Distribution | 1999 |
Effects of cilastatin on the pharmacokinetics of a new carbapenem, DA-1131, in rats, rabbits, and dogs.
Topics: Animals; Carbapenems; Cilastatin; Dipeptidases; Dogs; Drug Interactions; Metabolic Clearance Rate; Microvilli; Protease Inhibitors; Rabbits; Rats; Rats, Sprague-Dawley | 1999 |
Stability of new carbapenem DA-1131 to renal dipeptidase (dehydropeptidase I).
Topics: Animals; Carbapenems; Dipeptidases; Enzyme Stability; Imipenem; Meropenem; Substrate Specificity; Thienamycins | 2002 |
Effects of water deprivation for 72 hours on the pharmacokinetics of a new carbapenem, DA-1131, in rats.
Topics: Animals; Carbapenems; Male; Rats; Rats, Sprague-Dawley; Tissue Distribution; Water Deprivation | 2002 |